MedPath

Study of treatment starategy for patients with castration resistsnt prostate cancer using new hormonal agents before chemotherapy

Not Applicable
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000016783
Lead Sponsor
Department of urology, Tohoku University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1. Other malignancies 2. Prior chemotherapy (excluding estramuscin) 3. Steroids 4. Severe visceral dysfunction 5. Other clinical trial 6. Prior enzalutamide or abiraterone

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PSA resopnse
Secondary Outcome Measures
NameTimeMethod
QOL Duration before chemotherapy Skeletal related event Survival
© Copyright 2025. All Rights Reserved by MedPath